Human Papillomavirus 16 DNA Methylation Patterns and Investigation of Integration Status in Head and Neck Cancer Cases
- PMID: 37834041
- PMCID: PMC10572864
- DOI: 10.3390/ijms241914593
Human Papillomavirus 16 DNA Methylation Patterns and Investigation of Integration Status in Head and Neck Cancer Cases
Abstract
Persistent high-risk human papillomavirus (HPV) infection is a pivotal factor in the progression of cervical cancer. In recent years, an increasing interest has emerged in comprehending the influence of HPV on head and neck squamous cell carcinoma (HNSCC). Notably, it is well established that HPV-associated HNSCC show cases with distinct molecular and clinical attributes compared to HPV-negative cases. The present study delves into the epigenetic landscape of HPV16, specifically its L1 gene and untranslated region (UTR), through pyrosequencing, while the HPV16 DNA physical status was evaluated using E2/E6 ratio analysis in HPV16-positive HNSCC FFPE biopsies. Our findings reveal substantial methylation across six sites within the HPV16 L1 gene and seven sites in the UTR. Specifically, methylation percentages of two L1 CpG sites (7136, 7145) exhibit significant associations with tumor histological grade (p < 0.01), while proving concurrent methylation across multiple sites. The HPV16 DNA physical status was not correlated with the methylation of viral genome or tumor characteristics. This is the first study that examines epigenetic modifications and the HPV16 DNA physical status in Greek HNSCC patients. Our findings suggest an orchestrated epigenetic modulation among specific sites, impacting viral gene expression and intricate virus-host interactions.
Keywords: HNSCC; HPV16; L1; UTR methylation; viral integration.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.Int J Cancer. 2017 Apr 1;140(7):1571-1580. doi: 10.1002/ijc.30589. Epub 2017 Jan 9. Int J Cancer. 2017. PMID: 28006857 Free PMC article.
-
Integration and viral oncogene expression of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma and gastric cancer.J Med Virol. 2023 May;95(5):e28761. doi: 10.1002/jmv.28761. J Med Virol. 2023. PMID: 37212316
-
Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.Cancer Epidemiol Biomarkers Prev. 2022 Apr 1;31(4):858-869. doi: 10.1158/1055-9965.EPI-21-0922. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35064062 Free PMC article.
-
Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities.Virol J. 2021 Nov 8;18(1):217. doi: 10.1186/s12985-021-01688-9. Virol J. 2021. PMID: 34749746 Free PMC article. Review.
-
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.Lancet Oncol. 2014 Nov;15(12):1319-31. doi: 10.1016/S1470-2045(14)70471-1. Epub 2014 Oct 16. Lancet Oncol. 2014. PMID: 25439690
Cited by
-
Advances in the study of posttranslational modifications of histones in head and neck squamous cell carcinoma.Clin Epigenetics. 2024 Nov 21;16(1):165. doi: 10.1186/s13148-024-01785-w. Clin Epigenetics. 2024. PMID: 39574168 Free PMC article. Review.
-
Disruption Events in the HPV18 E1 and E2 Genes in Precancerous Cervical Lesions.Int J Mol Sci. 2025 Jul 20;26(14):6974. doi: 10.3390/ijms26146974. Int J Mol Sci. 2025. PMID: 40725221 Free PMC article.
-
Prevalence and Genotype Distribution of High-Risk HPV Genotypes Among Women in Greece: A Retrospective Analysis of 3500 Women.Cancers (Basel). 2025 Apr 9;17(8):1267. doi: 10.3390/cancers17081267. Cancers (Basel). 2025. PMID: 40282443 Free PMC article.
-
HPV16 E6 Oncogene Contributes to Cancer Immune Evasion by Regulating PD-L1 Expression through a miR-143/HIF-1a Pathway.Viruses. 2024 Jan 12;16(1):113. doi: 10.3390/v16010113. Viruses. 2024. PMID: 38257813 Free PMC article.
-
Treatment of tumor-associated macrophages with PD-1 monoclonal antibodies affects vascular generation in cervical cancer via the PD-1/IRE1α/SHP2/HIF1α signaling pathway.Aging (Albany NY). 2024 Aug 28;16(17):12335-12345. doi: 10.18632/aging.206090. Epub 2024 Aug 28. Aging (Albany NY). 2024. PMID: 39207449 Free PMC article.
References
-
- Vos T., Abajobir A.A., Abate K.H., Abbafati C., Abbas K.M., Abd-Allah F., Abdulkader R.S., Abdulle A.M., Abebo T.A., Abera S.F., et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–1259. doi: 10.1016/S0140-6736(17)32154-2. - DOI - PMC - PubMed
-
- Suzich J.A., Ghim S.J., Palmer-Hill F.J., White W.I., Tamura J.K., Bell J.A., Newsome J.A., Jenson A.B., Schlegel R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA. 1995;92:11553–11557. doi: 10.1073/pnas.92.25.11553. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical